Literature DB >> 25634857

Atropine sulfate for treatment of bradycardia in a patient with morbid obesity: what may happen when you least expect it.

Michele Carron1, Stefano Veronese1.   

Abstract

A 74-year-old morbidly obese man was scheduled for surgical repair of an incisional ventral hernia. Anaesthesia was induced with propofol and fentanyl, and maintained with desflurane. A second dose of fentanyl 0.2 mg, given before starting surgery, resulted in sinus bradycardia and mild decrease of arterial blood pressure. Atropine sulfate 0.5 mg was administered. One minute later, the ECG rhythm on the monitor changed to third degree atrioventricular block with a ventricular response rate of 40 beats/min associated with marked hypotension. Isoproterenol 0.02 mg reverted the atrioventricular block to sinus rhythm. Cardiac enzymes and ECG ruled out acute myocardial ischaemia. The surgical procedure and the recovery from anaesthesia were uneventful. The patient was discharged from the hospital on the fifth postoperative day. For the treatment of bradycardia atropine sulfate should be adjusted at least to lean body weight in order to avoid paradoxical heart rate response in patients with obesity. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25634857      PMCID: PMC4322279          DOI: 10.1136/bcr-2014-207596

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  11 in total

Review 1.  Obesity in anaesthesia and intensive care.

Authors:  J P Adams; P G Murphy
Journal:  Br J Anaesth       Date:  2000-07       Impact factor: 9.166

2.  High-degree atrioventricular block after the administration of atropine for sinus arrest during anesthesia.

Authors:  Koichi Maruyama; Noriaki Mochizuki; Katsumi Hara
Journal:  Can J Anaesth       Date:  2003-05       Impact factor: 5.063

Review 3.  Dose adjustment of anaesthetics in the morbidly obese.

Authors:  J Ingrande; H J M Lemmens
Journal:  Br J Anaesth       Date:  2010-12       Impact factor: 9.166

4.  Atrioventricular conduction block induced by low-dose atropine.

Authors:  K J Chin; S C Seow
Journal:  Anaesthesia       Date:  2005-09       Impact factor: 6.955

5.  Acute complete heart block during anesthesia in a patient with severe coronary artery disease: effect of scopolamine versus ischemia of the AV node.

Authors:  K W Park; E Lowenstein
Journal:  Anesthesiology       Date:  1991-08       Impact factor: 7.892

6.  Central vagotonic effects of atropine modulate spectral oscillations of sympathetic nerve activity.

Authors:  N Montano; C Cogliati; A Porta; M Pagani; A Malliani; K Narkiewicz; F M Abboud; C Birkett; V K Somers
Journal:  Circulation       Date:  1998-10-06       Impact factor: 29.690

7.  Simplified estimation of ideal and lean body weights in morbidly obese patients.

Authors:  M Carron; S Guzzinati; C Ori
Journal:  Br J Anaesth       Date:  2012-11       Impact factor: 9.166

8.  Quantification of lean bodyweight.

Authors:  Sarayut Janmahasatian; Stephen B Duffull; Susan Ash; Leigh C Ward; Nuala M Byrne; Bruce Green
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

Review 9.  Propofol and arrhythmias: two sides of the coin.

Authors:  Qiang Liu; Ai-ling Kong; Rong Chen; Cheng Qian; Shao-wen Liu; Bao-gui Sun; Le-xin Wang; Long-sheng Song; Jiang Hong
Journal:  Acta Pharmacol Sin       Date:  2011-06       Impact factor: 6.150

Review 10.  Pharmacokinetic implications for the clinical use of atropine, scopolamine and glycopyrrolate.

Authors:  J Kanto; U Klotz
Journal:  Acta Anaesthesiol Scand       Date:  1988-02       Impact factor: 2.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.